| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $275K | -69.4% |
| R&D Expense | $14.0M | -18.5% |
| SG&A Expense | $6.2M | -0.4% |
| Operating Income | -$19.9M | +11.5% |
| Interest Expense | $2K | -99.8% |
| Pre-tax Income | -$19.8M | +11.5% |
| Income Tax | $0 | — |
| Net Income | -$19.8M | +11.5% |
| EPS (Basic) | -$0.47 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.4M | -25.6% |
| Accounts Receivable | $175K | — |
| Current Assets | $7.5M | -20.5% |
| Total Assets | $8.0M | -19.0% |
| Current Liabilities | $2.5M | +12.5% |
| Long-term Debt | $101K | -42.3% |
| Total Liabilities | $2.8M | +14.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.1M | +24.6% |
| Capital Expenditures | $99K | +209.4% |
| Investing Cash Flow | -$99K | -209.4% |
| Financing Cash Flow | $17.0M | -27.2% |
| Free Cash Flow | -$19.2M | +24.3% |
| +39.7% |
| EPS (Diluted) | -$0.47 | +39.7% |
| Stockholders' Equity |
| $5.2M |
| -29.9% |